Dexcom (DXCM) Return on Equity (2011 - 2026)

Dexcom (DXCM) has 16 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity grew to 0.0% in Q1 2026 per DXCM's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 0.0% in Q1 2026 and troughed at 0.0% in Q2 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
• On a YoY basis, Return on Equity climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then jumped by 45 bps to 0.0% in 2023, then increased by 13 bps to 0.0% in 2024, then rose by 8 bps to 0.0% in 2025, then rose by 7 bps to 0.0% in 2026.
• Business Quant data shows DXCM's Return on Equity at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.